Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-382: hsa-mir-382, a microRNA, has been predicted to have two binding sites on the REST transcript, one at the first exon and one at the 3′ UTR, as determined by UCSC miRcode [PMC4297868]. In a study comparing control neurons and neurons derived from Fragile X Syndrome (FXS), it was found that hsa-mir-382 exhibited high levels in control neurons but markedly low levels in FXS-derived neurons [PMC4297868]. HNMT, a gene involved in histamine metabolism, is regulated by several microRNAs. Hsa-miR-3202 regulates HNMT in a culture with adalimumab [PMC9678002]. Hsa-miR-583 regulates HRH1 (a histamine receptor) independent of the drug added to the culture [PMC9678002]. Hsa-miR-1275 regulates SLC23A2 and HRH3 (histamine receptors) [PMC9678002]. Hsa-miR-4696 regulates HRH3 in a culture with CSA (cyclosporine A) [PMC9678002]. Additionally, hsa-mir-382 regulates HNMT in a culture with adalimumab [PMC9678002].
References:
[PMC4297868] - Darnell JC et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 2011 Jan 21;144(2): 253–265.
[PMC9678002] - Gao Y et al. Identification of miRNA–mRNA regulatory network associated with adalimumab treatment for rheumatoid arthritis by integrated analysis. BMC Musculoskelet Disord. 2021;22(1): 1005.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset